SurvNet: A low-complexity convolutional neural network for survival time classification of patients with glioblastoma

Background and objective: Malignant primary brain tumors cause the greatest number of years of life lost than any other cancer. Grade 4 glioma is particularly devastating: The median survival without any treatment is less than six months and with standard-of-care treatment is only 14.6 months. Accur...

全面介紹

書目詳細資料

發表在:	Heliyon
Main Authors:	Qiyuan Lyu, Mario Parreno-Centeno, João Paulo Papa, Esin Öztürk-Isik, Thomas C. Booth, Fumie Costen
格式:	Article
語言:	英语
出版:	Elsevier 2024-06-01
主題:	Brain tumor glioma glioblastoma Overall survival classification deep learning Magnetic resonance imaging convolutional neural network
在線閱讀:	http://www.sciencedirect.com/science/article/pii/S2405844024089011